SCHEMBL16623576

SCHEMBL16623576

N=C(c1ccc(N2CCOCC2)cc1)c1c(NC2CCC(F)(F)CC2)cc[nH]c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.35
BRD4 O60885 2/20 0.35
GSK3B P49841 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
USP30 Q70CQ3 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
PRKAA1 Q13131 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623573 0.84 MAPT (0.34) GSK3BUSP30JAK3KDM4EGHSR
SCHEMBL16623567 0.83 BRD4 (0.36) BRD4JAK1IDH1
SCHEMBL16623495 0.81 GHSR (0.36) JAK2JAK1JAK3KDM4EGHSR
SCHEMBL17849223 0.77 MAPT (0.41) GSK3BHDAC3HDAC4HDAC1HDAC7
SCHEMBL16623512 0.77 JAK1 (0.43) BRD4HDAC3HDAC1HDAC2HDAC6
SCHEMBL17849188 0.76 EGFR (0.40) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL17849247 0.75 MAPT (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16726651 0.73 NPC1 (0.41) BRD4GSK3BJAK2JAK1KDM4E
SCHEMBL17849227 0.72 TYK2 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL16623538 0.72 JAK1 (0.31) BRD4JAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed